Lantern Pharma 뉴스 - LTRN

기업명	주식 심볼	시장	주식 타입
Lantern Pharma Inc	LTRN	나스닥	보통주

	가격 변동	가격 변동 %	주식 가격	최근 거래 시간
	-0.23	-4.21%	5.23	13:00:00

개장가	저가	고가	종가	전일 종가
5.55	5.42	6.04	5.50	5.46

시세 정보 더보기 »

최근 뉴스

일자	시간	출처	제목
24/04/2024	21:00	BW	Lantern Pharma Launches “Webinar Wednesdays” Featuring..
22/04/2024	21:12	BW	Lantern Pharma Receives Regulatory Approval to Expand..
19/03/2024	05:02	BW	Lantern Pharma Reports Fourth Quarter & Fiscal Year 2023..
18/03/2024	20:12	IHMARKETNEWS	Anticipation Builds on Wall Street for Federal Reserve’s..
15/03/2024	21:00	BW	Lantern Pharma Announces Initial Patients Dosed in..
11/03/2024	20:30	BW	Lantern Pharma to Report Fourth Quarter and Fiscal Year 2023..
05/03/2024	22:01	BW	Lantern To Participate in H.C Wainwright & Co.’s (HCW) 1st..
04/03/2024	22:01	BW	Lantern Pharma's A.I. Platform, RADR®, Surpasses 60 Billion..
01/03/2024	11:54	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
15/02/2024	22:01	BW	Lantern Pharma Advances Unique ADC (Antibody Drug Conjugate)..
20/01/2024	06:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
17/01/2024	21:30	BW	Starlight Therapeutics, a Subsidiary of Lantern Pharma..
30/12/2023	06:05	EDGAR2	Form 8-K - Current report
01/12/2023	20:02	EDGAR2	Form SC 13D/A - General statement of acquisition of..
01/12/2023	20:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
30/11/2023	22:00	BW	FDA Grants Lantern Pharma Orphan Drug Designation for Drug..
25/11/2023	06:05	EDGAR2	Form 8-K - Current report
09/11/2023	06:05	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/2023	06:05	EDGAR2	Form 8-K - Current report
09/11/2023	06:01	BW	Lantern Pharma Reports Third Quarter 2023 Financial Results..
01/11/2023	21:00	BW	Lantern Pharma to Report Third Quarter 2023 Operating &..
21/10/2023	06:25	EDGAR2	Form 8-K - Current report
10/10/2023	21:00	BW	Lantern Pharma to Present at the ThinkEquity Conference on..
03/10/2023	21:00	BW	Lantern Pharma Announces Publication in Clinical Cancer..
25/09/2023	21:30	BW	Lantern Pharma Announces First Patient Dosed in the Phase 1..
18/09/2023	22:00	BW	Lantern Pharma Receives IND Clearance from FDA Enabling..
31/08/2023	21:00	BW	Lantern Pharma to Present Data Highlighting the Anti-Tumor..
28/08/2023	21:00	BW	Lantern Pharma Expands AI Capabilities of RADR® Platform to..
14/08/2023	21:30	BW	Lantern Pharma Receives Notice of US Patent Allowance for..
10/08/2023	05:05	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/08/2023	05:05	EDGAR2	Form 8-K - Current report
10/08/2023	05:01	BW	Lantern Pharma Reports Second Quarter 2023 Financial Results..
02/08/2023	21:00	BW	Lantern Pharma to Report Second Quarter 2023 Operating &..
17/07/2023	21:00	BW	Lantern Pharma to Participate and Present at Multiple..
26/06/2023	21:30	BW	Oncotarget Publishes New Data by Lantern Pharma, an AI..
12/06/2023	21:30	BW	Lantern Pharma Receives FDA Clearance of IND Application for..
08/06/2023	22:00	BW	Lantern Pharma Leverages AI Platform, RADR®, to Develop..
17/05/2023	21:00	BW	Lantern Pharma to Present at the Lytham Partners Spring 2023..
10/05/2023	05:01	BW	Lantern Pharma Reports First Quarter 2023 Financial Results..
03/05/2023	22:00	PRNUS	Lantern Pharma Selects REPROCELL USA to Provide Support for..
03/05/2023	05:01	BW	Lantern Pharma to Report First Quarter 2023 Operating &..
02/05/2023	20:30	BW	Lantern Pharma Develops Top-Ranked AI Algorithms to Predict..

이 » 주식의 기사 더보기;

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

LTRN Lantern Pharma Inc

최근 뉴스

LTRN 과거 데이터 - 1일

LTRN 과거 데이터 - 1년

최근 히스토리

회사 소개

사업

Popular

앱 받기

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

Lantern Pharma Inc (LTRN) 뉴스

LTRN Lantern Pharma Inc

최근 뉴스

LTRN 과거 데이터 - 1일

LTRN 과거 데이터 - 1년

최근 히스토리

회사 소개

사업

Popular

앱 받기